Retension Pharmaceuticals
RTSN12.2700.16% ( +0.020 )
Forecast
Forecast & Rating3 analysts currently cover Retension Pharmaceuticals, of which 3 give a positive rating. The average price target is $51.67, about 321.1% upside from the current price of $12.27. Coverage is limited, so the data is for reference only. Data as of Nov 10, 2026; this does not constitute investment advice.
Nov 9, 2026Price forecast
$51.67321.08%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateNov 13, 2026
Forecast met0.0%
Stock price$12.27
Avg. target$51.7
High target$55
Low target$50
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.